Oruka Therapeutics, Inc. ORKA
NASDAQ · United States · Health Technology
$83.04-0.25 (-0.30%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.55 | -0.51 | -7.3% | $0 | — | +5.9%$98.82→$104.68 |
| Q1 2026 | 2026-05-13 | -0.48 | -0.54 | +11.1% | — | — | -1.2%$64.65→$63.90 |
| Q4 2025 | 2026-03-12 | -0.45 | -0.62 | +27.4% | — | — | +16.2%$34.41→$40.00 |
| Q3 2025 | 2025-11-12 | -0.55 | -0.52 | -5.8% | — | — | -6.5%$28.20→$26.38 |
| Q2 2025 | 2025-08-11 | -0.46 | -0.43 | -7.0% | — | — | — |
| Q1 2025 | 2025-05-14 | -0.40 | -0.44 | +9.1% | — | — | — |
| Q4 2024 | 2025-03-06 | -0.49 | -0.41 | -19.5% | — | — | — |
| Q3 2024 | 2024-11-13 | -1.46 | -0.38 | -284.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.